Skip to content
AnalystLens

MORGAN STANLEY 8-K Report, Corporate Update (Jul 1, 2025)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed July 1, 2025
Period End
July 1, 2025
In the record · 2016–202610-K1110-Q328-K118

MS filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 118 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jul ’19Jul ’19
  2. Leadership change8-K · Nov ’21Nov ’21
  3. Leadership change8-K · May ’24May ’24

Summary

Summary of the 8-K filed July 1, 2025. Cited figures are marked; the original filing is the authoritative source.

Morgan Stanley (NYSE: MS) announced on July 1, 2025 a capital return package following the Federal Reserve's 2025 CCAR stress test results.

The quarterly common stock dividend will rise 7.5 cents, from $0.925 to $1.00a per share, beginning with the dividend expected to be declared in the third quarter of 2025. The Board also reauthorized a multi-year common equity share repurchase program of up to $20 billion with no set expiration date, starting in the third quarter of 2025. Repurchases will be executed opportunistically based on market conditions, capital position, and the economic and earnings outlook.

The key regulatory input is the Stress Capital Buffer (SCB), which the Fed's June 27, 2025 results set at 5.1%b for October 1, 2025 through September 30, 2026. Combined with other elements of the regulatory capital framework, this yields an aggregate U.S. Basel III Standardized Approach CET1 ratio requirement of 12.6%, compared with the firm's actual CET1 ratio of 15.3% as of March 31, 2025. That implies roughly 270 basis points of headroom above the requirement, which underpins the capacity for the higher dividend and buyback.

The company characterized the stress test outcome as an improvement, and CEO Ted Pick tied it to the franchise's scale, global reach, and durable returns. Investors should note that the Federal Reserve has proposed a rulemaking that could change how SCBs are calculated for large bank holding companies.

If adopted, it could alter Morgan Stanley's SCB and the capital distribution capacity implied by these announcements, and the company has committed to update investors if that occurs. The buyback is described as flexible rather than a fixed commitment, so the actual pace of repurchases will depend on future market and earnings conditions.

Key Highlights

  1. Quarterly dividend increases 7.5 cents to $1.00 per share from $0.925, effective with the dividend expected to be declared in Q3 2025 (a roughly 8.1% increase).
  2. New multi-year common equity share repurchase program authorized for up to $20 billion, with no set expiration date, beginning in Q3 2025.
  3. Stress Capital Buffer set at 5.1% for October 1, 2025 through September 30, 2026, based on the Fed's 2025 supervisory stress test results released June 27, 2025.
  4. Implied aggregate U.S. Basel III Standardized CET1 requirement of 12.6%, versus an actual CET1 ratio of 15.3% at March 31, 2025, leaving about 270 bps of headroom.
  5. Buybacks are opportunistic and subject to market conditions, capital position, and the economic and earnings outlook, rather than a fixed repurchase schedule.
  6. The Fed has proposed a rulemaking that could change SCB calculation methodology for large bank holding companies; Morgan Stanley will update if a final rule alters its SCB.
  7. Management (CEO Ted Pick) characterized the improved stress test results as reflecting the strength and durability of the franchise.

Frequently Asked Questions

  1. How much will Morgan Stanley's dividend increase and when does it take effect?

    The quarterly common dividend rises from $0.925 to $1.00 per share, an increase of 7.5 cents. The higher amount applies starting with the dividend expected to be declared by the Board in the third quarter of 2025.

  2. What is the new share repurchase authorization?

    The Board reauthorized a multi-year common equity share repurchase program of up to $20 billion with no set expiration date, beginning in the third quarter of 2025. Purchases will be made from time to time at prices management considers appropriate.

  3. What does the 5.1% Stress Capital Buffer mean for Morgan Stanley?

    The SCB is the capital cushion added to minimum requirements based on stress test results. A 5.1% SCB applies from October 1, 2025 to September 30, 2026. Together with other framework elements, it produces an aggregate CET1 requirement of 12.6%, against the firm's 15.3% CET1 ratio at March 31, 2025.

  4. Could the Fed's proposed rule change these capital requirements?

    Yes, potentially. The Fed has proposed changing how SCBs are calculated for large bank holding companies. If adopted, it could change Morgan Stanley's SCB, and the company has said it will provide updated regulatory capital information if a final rule is issued. The outcome is not yet determined.

  5. Is the $20 billion buyback a guaranteed commitment to shareholders?

    No. The program is an authorization, not a required schedule. Repurchases will depend on current market conditions, the firm's capital position, and its future economic and earnings outlook, so actual timing and volume may vary.